Vertigo and H4 Antagonist Effect on Vestibular Symptoms

doi:10.4236/oalib.1110164

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

查看量	下载量

Open Access Library Journal 10 2023

查看所有领域

Vertigo and H4 Antagonist Effect on Vestibular Symptoms

DOI: 10.4236/oalib.1110164, PP. 1-21

Leena Saeed, Hanna Elbashir Mohamed Ali, Zeinab Abdalgadeer Ali Abdalla, Sarra Fadlalla Elabbas, Marwa Eltaj Eltayeb, Wafa Mukhtar Mohamed Mukhtar

Subject Areas: Pharmacology

Keywords: Vertigo, Dizziness, Peripheral Vertigo, Central Vertigo

Full-Text Cite this paper Add to My Lib

Abstract

Vertigo is a condition when a patient feels that the objects around him are moving, and this condition can lead to falls and serious incidences. Vertigo has various etiologies including central, peripheral, psychogenic, and medication-induced vertigo. The most common cause is benign paroxysmal positional vertigo (BPPV) then Meniere’s disease and labyrinthitis should be in the differential diagnosis. Ruling out serious conditions such as stroke is important. Various treatment options are used for vestibular symptoms and vestibular rehabilitation shows a positive result. Management of vertigo is the same for a long time despite the partial effect, unwanted side effects due to some drugs, and the need for multiple medications to relieve the symptoms in some patients. More effective treatment with lesser side effects needs to be used. Recently some in vivo trials come into view that H4 antagonist such as SENS-111 is effective in treating vestibular symptoms. These medications work by blocking the action of histamine, a chemical messenger involved in the immune response. More clinical trials and research need to be done on this type of treatment and other treatment options as this will lead to positive transformation in the future.

Cite this paper

Saeed, L. , Ali, H. E. M. , Abdalla, Z. A. A. , Elabbas, S. F. , Eltayeb, M. E. and Mukhtar, W. M. M. (2023). Vertigo and H4 Antagonist Effect on Vestibular Symptoms. Open Access Library Journal, 10, e164. doi: http://dx.doi.org/10.4236/oalib.1110164.

References

[1]	Sorathia, S., Agrawal, Y. and Schubert, M.C. (2018) Dizziness and the Otolaryngology Point of View. Medical Clinics of North America, 102, 1001-1012. https://doi.org/10.1016/j.mcna.2018.06.004
[2]	Zwergal, A., Möhwald, K. and Dieterich, M. (2017) Schwindel in der Notaufnahme [Vertigo and Dizziness in the Emergency Room]. Nervenarzt, 88, 587-596. https://doi.org/10.1007/s00115-017-0342-y
[3]	Hogue, J.D. (2015) Office Evaluation of Dizziness. Primary Care: Clinics in Office Practice, 42, 249-258. https://doi.org/10.1016/j.pop.2015.01.004
[4]	Tsai, M.-S., Lee, L.-A., Tsai, Y.-T., Yang, Y.-H., Liu, C.-Y., Lin, M.-H., Hsu, C.-M., Chen, C.-K. and Li, H.-Y. (2018) Sleep Apnea and Risk of Vertigo: A Nationwide Population-Based Cohort Study. Laryngoscope, 128, 763-768.
[5]	Gerb, J., Becker-Bense, S., Zwergal, A. and Huppert, D. (2022) Vestibular Syndromes after COVID-19 Vaccination: A Prospective Cohort Study. European Journal of Neurology, 29, 3693-3700. https://doi.org/10.1111/ene.15546
[6]	Jahn, K. and Dieterich, M. (2011) Recent Advances in the Diagnosis and Treatment of Balance Disorders. Journal of Neurology, 258, 2305-2308. https://doi.org/10.1007/s00415-011-6286-4
[7]	Taylor, J. and Goodkin, H.P. (2011) Dizziness and Vertigo in the Adolescent. Otolaryngologic Clinics of North America, 44, 309-321. https://doi.org/10.1016/j.otc.2011.01.004
[8]	Kim, J.-S., Newman-Toker, D.E., Kerber, K.A., Jahn, K., Bertholon, P., Waterston, J., Lee, H., Bisdorff, A. and Strupp, M. (2022) Vascular Vertigo and Dizziness: Diagnostic Criteria. Journal of Vestibular Research, 32, 205-222. https://doi.org/10.3233/VES-210169
[9]	Kovacs, E., Wang, X. and Grill, E. (2019) Economic Burden of Vertigo: A Systematic Review. Health Economics Review, 9, Article No. 37. https://doi.org/10.1186/s13561-019-0258-2
[10]	You, P., Instrum, R. and Parnes, L. (2019) Benign Paroxysmal Positional Vertigo. Laryngoscope Investigative Otolaryngology, 4, 116-123. https://doi.org/10.1002/lio2.230
[11]	Kim, H.J., Lee, J.O., Choi, J.Y. and Kim, J.S. (2020) Etiologic Distribution of Dizziness and Vertigo in a Referral-Based Dizziness Clinic in South Korea. Journal of Neurology, 267, 2252-2259. https://doi.org/10.1007/s00415-020-09831-2
[12]	Petremann, M., Gueguen, C., Delgado Betancourt, V., Wersinger, E. and Dyhrfjeld-Johnsen, J. (2020) Effect of the Novel Histamine H4 Receptor Antagonist SENS-111 on Spontaneous Nystagmus in a Rat Model of Acute Unilateral Vestibular Loss. British Journal of Pharmacology, 177, 623-633. https://doi.org/10.1111/bph.14803
[13]	Yetiser, S. (2020) Review of the Pathology Underlying Benign Paroxysmal Positional Vertigo. Journal of International Medical Research, 48, Article ID: 300060519892370. https://doi.org/10.1177/0300060519892370
[14]	Lou, Y., Cai, M., Xu, L., Wang, Y., Zhuang, L. and Liu, X. (2020) Efficacy of BPPV Diagnosis and Treatment System for Benign Paroxysmal Positional Vertigo. American Journal of Otolaryngology, 41, Article ID: 102412. https://doi.org/10.1016/j.amjoto.2020.102412
[15]	Instrum, R.S. and Parnes, L.S. (2019) Benign Paroxysmal Positional Vertigo. In: Advances in Oto-Rhino-Laryngology, Vol. 82, Karger Publishers, Basel, 67-76. https://doi.org/10.1159/000490273
[16]	Nuti, D., Zee, D.S. and Mandalà, M. (2020) Benign Paroxysmal Positional Vertigo: What We Do and Do Not Know. Seminars in Neurology, 40, 49-58. https://doi.org/10.1055/s-0039-3402733
[17]	Wu, P., Cao, W., Hu, Y. and Li, H. (2019) Effects of Vestibular Rehabilitation, with or without Betahistine, on Managing Residual Dizziness after Successful Repositioning Manoeuvres in Patients with Benign Paroxysmal Positional Vertigo: A Protocol for a Randomised Controlled Trial. BMJ Open, 9, e026711. https://doi.org/10.1136/bmjopen-2018-026711
[18]	Inagaki, T., Suzuki, M., Otsuka, K., Kitajima, N., Furuya, M., Ogawa, Y. and Takenouchi, T. (2006) Model Experiments of BPPV Using Isolated Utricle and Posterior Semicircular Canal. Auris Nasus Larynx, 33, 129-134. https://doi.org/10.1016/j.anl.2005.09.001
[19]	Sayin, I., Koç, R.H., Temirbekov, D., Gunes, S., Cirak, M.and Yazici, Z.M. (2022) Betahistine Addon Therapy for Treatment of Subjects with Posterior Benign Paroxysmal Positional Vertigo: A Randomized Controlled Trial. Brazilian Journal of Otorhinolaryngology, 88, 421-426. https://doi.org/10.1016/j.bjorl.2020.07.011
[20]	Elmoursy, M.M. and Abbas, A.S. (2021) The Role of Low Levels of Vitamin D as a CO-Factor in the Relapse of Benign Paroxysmal Positional Vertigo (BPPV). American Journal of Otolaryngology, 42, Article ID: 103134. https://doi.org/10.1016/j.amjoto.2021.103134
[21]	Bastaki, K., El Anbari, M., Ghuloum, S. and Jithesh, P.V. (2021) Prescription Pattern and off-Label Use of Antipsychotics in a Middle Eastern Population. Frontiers in Pharmacology, 12, Article 753845. https://doi.org/10.3389/fphar.2021.753845
[22]	Magnan, J., Özgirgin, O.N., Trabalzini, F., Lacour, M., Escamez, A.L., Magnusson, M., Güneri, E.A., Guyot, J.P., Nuti, D. and Mandalà, M. (2018) European Position Statement on Diagnosis, and Treatment of Meniere’s Disease. The Journal of International Advanced Otology, 14, 317-321. https://doi.org/10.5152/iao.2018.140818
[23]	Koenen, L. and Andaloro, C. (2022) Meniere Disease. In: StatPearls, StatPearls Publishing, Treasure Island.
[24]	Thai-Van, H., Bounaix, M.-J. and Fraysse, B. (2001) Menière’s Disease: Pathophysiology and Treatment. Drugs, 61, 1089-1102. https://doi.org/10.2165/00003495-200161080-00005
[25]	Hussain, K., Murdin, L. and Schilder, A.G.M. (2018) Restriction of Salt, Caffeine and Alcohol Intake for the Treatment of Ménière’s Disease or Syndrome. Cochrane Database of Systematic Reviews, No. 12, Article No. CD012173. https://doi.org/10.1002/14651858.CD012173.pub2
[26]	Lopez-Escamez, J.A., et al. (2015) Diagnostic Criteriafor Menière’s Disease. Journal of Vestibular Research, 25, 1-7. https://doi.org/10.3233/VES-150549
[27]	Watkinson, J.C. and Clarke, R.W. (2018) Scott-Brown’s Otorhinolaryngology and Head and Neck Surgery: Volume 1: Basic Sciences, Endocrine Surgery, Rhinology. CRC Press, Boca Raton.
[28]	Conte, G., Lo Russo, F.M., Calloni, S.F., Sina, C., Barozzi, S., Di Berardino, F., Scola, E., Palumbo, G., Zanetti, D. and Triulzi, F.M. (2018) MR Imaging of Endolymphatic Hydrops in Ménière’s Disease: Not All That Glitters Is Gold. ACTA Otorhinolaryngologica Italica, 38, 369-376. https://doi.org/10.14639/0392-100X-1986
[29]	Strupp, M., Dlugaiczyk, J., Ertl-Wagner, B.B., Rujescu, D., Westhofen, M. and Dieterich, M. (2020) Vestibular Disorders. DÄ International, 117, 300-310. https://doi.org/10.3238/arztebl.2020.0300
[30]	McNiven, N.D., Deutsch, P.G., Carlin, J.E. and Trotter, M.I. (2021) Ménière’s Disease: Management in Primary Care. British Journal of General Practice, 71, 571-572. https://doi.org/10.3399/bjgp21X717989
[31]	Molnár, A., Maihoub, S., Gáborján, A., Tamás, L. and Szirmai, á. (2020) Intratympanic Gentamycine for Ménière’s Disease: Is There a Selective Vestibulotoxic Effect? European Archives of Oto-Rhino-Laryngology, 277, 1949-1954. https://doi.org/10.1007/s00405-020-05901-3
[32]	Naples, J.G., Henry, L., Brant, J.A., Eliades, S.J. and Ruckenstein, M.J. (2019) Intratympanic Therapies in Ménière Disease: Evaluation of Outcomes and Early Vertigo Control. Laryngoscope, 129, 216-221. https://doi.org/10.1002/lary.27392
[33]	Smith, T., Rider, J., Cen, S. and Borger, J. (2022) Vestibular Neuronitis. In: StatPearls, StatPearls Publishing, Treasure Island.
[34]	Kim, J.-S. (2020) When the Room Is Spinning: Experience of Vestibular Neuritis by a Neurotologist. Frontiers in Neurology, 11, Article 157. https://doi.org/10.3389/fneur.2020.00157
[35]	Le, T.N., Westerberg, B.D. and Lea, J. (2019) Vestibular Neuritis: Recent Advances in Etiology, Diagnostic Evaluation, and Treatment. In: Advances in Oto-Rhino-Laryngology, Vol. 82, Karger Publishers, Basel, 87-92. https://doi.org/10.1159/000490275
[36]	Bramer, S., Jaffe, Y. and Sivagnanaratnam, A. (2022) Vestibular Neuronitis after COVID-19 Vaccination. BMJ Case Reports, 15, e247234. https://doi.org/10.1136/bcr-2021-247234
[37]	Bae, C.H., Na, H.G. and Choi, Y.S. (2022) Current Diagnosis and Treatment of Vestibular Neuritis: A Narrative Review. Journal of Yeungnam Medical Science, 39, 81-88. https://doi.org/10.12701/yujm.2021.01228
[38]	Malayala, S.V. and Raza, A. (2020) A Case of COVID-19-Induced Vestibular Neuritis. Cureus, 12, e8918. https://doi.org/10.7759/cureus.8918
[39]	Walker, M.F. (2009) Treatment of Vestibular Neuritis. Current Treatment Options in Neurology, 11, 41-45. https://doi.org/10.1007/s11940-009-0006-8
[40]	Sjögren, J., Magnusson, M., Tjernström, F. and Karlberg, M. (2019) Steroids for Acute Vestibular Neuronitis—The Earlier the Treatment, the Better the Outcome? Otology & Neurotology, 40, 372-374. https://doi.org/10.1097/MAO.0000000000002106
[41]	Perret, M., Bernard, A., Rahmani, A., Manckoundia, P. and Putot, A. (2021) Acute Labyrinthitis Revealing COVID-19. Diagnostics, 11, Article No. 482. https://doi.org/10.3390/diagnostics11030482
[42]	Taxak, P. and Ram, C. (2020) Labyrinthitis and Labyrinthitis Ossificans—A Case Report and Review of the Literature. Journal of Radiology Case Reports, 14, 1-6. https://doi.org/10.3941/jrcr.v14i5.3706
[43]	Uraguchi, K., Kariya, S. and Ando, M. (2022) Labyrinthitis Ossificans Following Severe Acute Otitis Media. Clinical Case Reports, 10, e05898. https://doi.org/10.1002/ccr3.5898
[44]	Benson, J.C., Carlson, M.L. and Lane, J.I. (2020) MRI of the Internal Auditory Canal, Labyrinth, and Middle Ear: How We Do It. Radiology, 297, 252-265. https://doi.org/10.1148/radiol.2020201767
[45]	Barkwill, D. and Arora, R. (2021) Treasure Island. StatPearls Publishing, Treasure Island.
[46]	Bokhary, H., Chaudhry, S. and Abidi, S.M.R. (2021) Labyrinthitis: A Rare Consequence of COVID-19 Infection. Cureus, 13, e17121. https://doi.org/10.7759/cureus.17121
[47]	Hamrang-Yousefi, S., Ng, J. and Andaloro, C. (2022) Eustachian Tube Dysfunction. In: StatPearls, StatPearls Publishing, Treasure Island.
[48]	Holm, N.H., Møller, M.N., Larsen, P.L., Wanscher, J.H., Glad, H., Gaihede, M. and Ovesen, T. (2019) [Workup and Treatment of Eustachian Tube Dysfunction in Adults]. Ugeskrift for Laeger, 181, Article No. V03180209. (In Danish)
[49]	Siow, J.-K. and Tan, J.-L. (2020) Indications for Eustachian Tube Dilation. Current Opinion in Otolaryngology & Head and Neck Surgery, 28, 31-35. https://doi.org/10.1097/MOO.0000000000000601
[50]	Tucci, D.L., et al. (2019) Clinical Consensus Statement: Balloon Dilation of the Eustachian Tube. Otolaryngology—Head and Neck Surgery, 161, 6-17. https://doi.org/10.1177/0194599819848423
[51]	Shan, A., Ward, B.K., Goman, A.M., Betz, J.F., Reed, N.S., Poe, D.S. and Nieman, C.L. (2019) Prevalence of Eustachian Tube Dysfunction in Adults in the United States. JAMA Otolaryngology—Head & Neck Surgery, 145, 974-975. https://doi.org/10.1001/jamaoto.2019.1917
[52]	Sudhoff, H.H. and Mueller, S. (2018) Treatment of Pharyngotympanic Tube Dysfunction. Auris Nasus Larynx, 45, 207-214. https://doi.org/10.1016/j.anl.2017.07.001
[53]	Adil, E. and Poe, D. (2014) What Is the Full Range of Medical and Surgical Treatments Available for Patients with Eustachian Tube Dysfunction? Current Opinion in Otolaryngology & Head and Neck Surgery, 22, 8-15. https://doi.org/10.1097/MOO.0000000000000020
[54]	Lui, F., Foris, L.A., Willner, K. and Tadi, P. (2022) Central Vertigo. In: StatPearls, StatPearls Publishing, Treasure Island.
[55]	Cherchi, M. and Hain, T.C. (2011) Migraine-Associated Vertigo. Otolaryngologic Clinics of North America, 44, 367-375. https://doi.org/10.1016/j.otc.2011.01.008
[56]	Wang, Y., Liu, J., Cui, Z., Yan, L. and Si, J. (2018) Analysis of Risk Factors in Patients with Peripheral Vertigo or Central Vertigo. Neurologist, 23, 75-78. https://doi.org/10.1097/NRL.0000000000000179
[57]	Kim, B.J., Jang, S.-K., Kim, Y.-H., Lee, E.-J., Chang, J.Y., Kwon, S.U., Kim, J.S. and Kang, D.-W. (2021) Diagnosis of Acute Central Dizziness with Simple Clinical Information Using Machine Learning. Frontiers in Neurology, 12, Article 691057. https://doi.org/10.3389/fneur.2021.691057
[58]	Jiang, C., Lekshminarayanan, A., Balkaya, I., Uddin, A., Bavishi, S. and Altschuler, E. (2022) Treatment of Central Vertigo with Low Dose Olanzapine: Report of Two Cases. Cureus, 14, e22647. https://doi.org/10.7759/cureus.22647
[59]	Gerlier, C., Hoarau, M., Fels, A., Vitaux, H., Mousset, C., Farhat, W., Firmin, M., Pouyet, V., Paoli, A., Chatellier, G. and Ganansia, O. (2021) Differentiating Central from Peripheral Causes of Acute Vertigo in an Emergency Setting with the HINTS, STANDING, and ABCD2 Tests: A Diagnostic Cohort Study. Academic Emergency Medicine, 28, 1368-1378. https://doi.org/10.1111/acem.14337
[60]	Cohen, H.S. (2019) A Review on Screening Tests for Vestibular Disorders. Journal of Neurophysiology, 122, 81-92. https://doi.org/10.1152/jn.00819.2018
[61]	Kattah, J.C. (2018) Use of HINTS in the Acute Vestibular Syndrome. An Overview. Stroke and Vascular Neurology, 3, 190-196. https://doi.org/10.1136/svn-2018-000160
[62]	Wu, C.-N., Luo, S.-D., Chen, S.-F., Huang, C.-W., Chiang, P.-L., Hwang, C.-F., Yang, C.-H., Ho, C.-H., Cheng, W.-D., Lin, C.-Y. and Li, Y.-L. (2022) Applicability of Oculomotor Tests for Predicting Central Vestibular Disorder Using Principal Component Analysis. Journal of Personalized Medicine, 12, Article No. 203. https://doi.org/10.3390/jpm12020203
[63]	Flourou, C., Tofarides, A. and Parperis, K. (2020) A 52-Year-Old Man with Vertigo: A Common Symptom or an Urgent Syndrome? Journal of Medical Cases, 11, 221-223. https://doi.org/10.14740/jmc3525
[64]	Kerber, K.A., Meurer, W.J., Brown, D.L., Burke, J.F., Hofer, T.P., Tsodikov, A., Hoeffner, E.G., Fendrick, A.M., Adelman, E.E. and Morgenstern, L.B. (2015) Stroke Risk Stratification in Acute Dizziness Presentations: A Prospective Imaging-Based Study. Neurology, 85, 1869-1878. https://doi.org/10.1212/WNL.0000000000002141
[65]	Swartz, R.H. and Kern, R.Z. (2004) Migraine Is Associated with Magnetic Resonance Imaging White Matter Abnormalities: A Meta-Analysis. Archives of Neurology, 61, 1366-1368. https://doi.org/10.1001/archneur.61.9.1366
[66]	Sankalia, D., Kothari, S. and Phalgune, D.S. (2021) Diagnosing Stroke in Acute Vertigo: Sensitivity and Specificity of HINTS Battery in Indian Population. Neurology India, 69, 97-101. https://doi.org/10.4103/0028-3886.310089
[67]	Zwergal, A., Feil, K., Schniepp, R. and Strupp, M. (2020) Cerebellar Dizziness and Vertigo: Etiologies, Diagnostic Assessment, and Treatment. Seminars in Neurology, 40, 87-96. https://doi.org/10.1055/s-0039-3400315
[68]	Raymond, M.J. and Vivas, E.X. (2021) Current and Emerging Medical Therapies for Dizziness. Otolaryngologic Clinics of North America, 54, 1037-1056. https://doi.org/10.1016/j.otc.2021.05.019
[69]	Sutherland, A., Naessens, K., Plugge, E., Ware, L., Head, K., Burton, M.J. and Wee, B. (2018) Olanzapine for the Prevention and Treatment of Cancer-Related Nausea and Vomiting in Adults. Cochrane Database of Systematic Reviews, No. 9, Article No. CD012555. https://doi.org/10.1002/14651858.CD012555.pub2
[70]	Tanoshima, R., Khan, A., Biala, A.K., et al. (2019) Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database. The Journal of Clinical Pharmacology, 3, 356-363. https://doi.org/10.1002/jcph.1336
[71]	Lanvers-Kaminsky, C., Zehnhoff-Dinnesen, A.a., Parfitt, R. and Ciarimboli, G. (2017) Drug-Induced Ototoxicity: Mechanisms, Pharmacogenetics, and Protective Strategies. Clinical Pharmacology & Therapeutics, 4, 491-500. https://doi.org/10.1002/cpt.603
[72]	Rizk, H.G., et al. (2020) Drug-Induced Ototoxicity: A Comprehensive Review and Reference Guide. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 40, 1265-1275. https://doi.org/10.1002/phar.2478
[73]	Osoba, M.Y., Rao, A.K., Agrawal, S.K. and Lalwani, A.K. (2019) Balance and Gait in the Elderly: A Contemporary Review. Laryngoscope Investigative Otolaryngology, 1, 143-153. https://doi.org/10.1002/lio2.252
[74]	MEDSAFE (2022) Medicine-Induced Vertigo. https://medsafe.govt.nz/profs/PUArticles/March2017/MedicineInducedVertigo.htm
[75]	Kelm, Z., Klapchar, K., Kieliszak, C.R. and Selinsky, C. (2018) Psychogenic Dizziness: An Important but Overlooked Differential Diagnosis in the Workup of the Dizzy Patient. Journal of Osteopathic Medicine, 118, e22-e27. https://doi.org/10.7556/jaoa.2018.066
[76]	Pan, Q., Zhang, Y., Long, T., He, W., Zhang, S., Fan, Y. and Zhou, J. (2018) Diagnosis of Vertigo and Dizziness Syndromes in a Neurological Outpatient Clinic. European Neurology, 79, 287-294. https://doi.org/10.1159/000489639
[77]	Li, C., Guo, D., Ma, X., Liu, S., Liu, M. and Zhou, L. (2021) The Impact of Coronavirus Disease 2019 Epidemic on Dizziness/Vertigo Outpatients in a Neurological Clinic in China. Frontiers in Neurology, 12, Article 663173. https://doi.org/10.3389/fneur.2021.663173
[78]	Post, R.E. and Dickerson, L.M. (2010) Dizziness: A Diagnostic Approach. American Family Physician, 82, 361-368.
[79]	Staab, J.P. and Ruckenstein, M.J. (2007) Expanding the Differential Diagnosis of Chronic Dizziness. Archives of Otorhinolaryngology—Head & Neck Surgery, 133, 170-176. https://doi.org/10.1001/archotol.133.2.170
[80]	Gupta, A. (2018) An Update on the Treatment of Vertigo and Dizziness. Indian Journal of Clinical Practice, 29, 121-124.
[81]	Wegner, I., Hall, D.A., Smit, A.L., McFerran, D. and Stegeman, I. (2018) Betahistine for Tinnitus. Cochrane Database of Systematic Reviews, No. 12, Article No. CD013093. https://doi.org/10.1002/14651858.CD013093.pub2
[82]	Devantier, L., Hougaard, D., Händel, M.N., Liviu-Adelin Guldfred, F., Schmidt, J.H., Djurhuus, B. and Callesen, H.E. (2020) Using Betahistine in the Treatment of Patients with Menière’s Disease: A Meta-Analysis with the Current Randomized-Controlled Evidence. Acta Oto-Laryngologica, 140, 845-853. https://doi.org/10.1080/00016489.2020.1777326
[83]	Molnár, A., Maihoub, S., Tamás, L. and Szirmai, á. (2021) Effectiveness of Intratympanic Dexamethasone for the Treatment of Vertigo Attacks in Patients with Ménière’s Disease Compared with Betahistine Pharmacotherapy. Journal of International Medical Research, 49, Article ID: 300060520985647. https://doi.org/10.1177/0300060520985647
[84]	Bhattacharyya, N., Gubbels, S.P., Schwartz, S.R., et al. (2017) Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) Executive Summary. Otolaryngology—Head and Neck Surgery, 156, 403-416. https://doi.org/10.1177/0194599816689660
[85]	Swain, S.K. (2020) Pharmacotherapy for Vertigo: A Current Perspective. International Journal of Otorhinolaryngology and Head and Neck Surgery, 6, 1400-1406. https://doi.org/10.18203/issn.2454-5929.ijohns20202806
[86]	AIFA (2021) Riassunto Delle Caratteristiche del Prodotto-Dimenidrinato. AIFA (Agenzia Italiana del Farmaco), Rome.
[87]	Saberi, A., Pourshafie, S.H., Kazemnejad-Leili, E., Nemati, S., Sutohian, S. and Sayad-Fathi, S. (2019) Ondansetron or Promethazine: Which One Is Better for the Treatment of Acute Peripheral Vertigo? American Journal of Otolaryngology, 40, 10-15. https://doi.org/10.1016/j.amjoto.2018.09.010
[88]	Guerra, J. and Cacabelos, R. (2019) Pharmacoepigenetics of Vertigo and Related Vestibular Syndromes. In: Cacabelos, R., Ed., Pharmacoepigenetics, Vol. 10, Academic Press, Cambridge, 755-779. https://doi.org/10.1016/B978-0-12-813939-4.00028-0
[89]	Viola, P., Marcianò, G., Casarella, A., Pisani, D., Astorina, A., Scarpa, A., et al. (2022) The Pharmacological Treatment of Pediatric Vertigo. Children, 9, Article No. 584. https://doi.org/10.3390/children9050584
[90]	Asadi, P., Zia Ziabari, S.M., Majdi, A., Vatanparast, K. and Naseri Alavi, S.A. (2019) Cinnarizine/Betahistine Combination vs. the Respective Monotherapies in Acute Peripheral Vertigo: A Randomized Triple-Blind Placebo-Controlled Trial. European Journal of Clinical Pharmacology, 75, 1513-1519. https://doi.org/10.1007/s00228-019-02741-x
[91]	AIFA (2016) Riassunto Delle Caratteristiche del Prodotto-Flunarizina. AIFA (Agenzia Italiana del Farmaco), Rome.
[92]	Babu, S., Schutt, C.A. and Bojrab, D.I. (2019) Diagnosis and Treatment of Vestibular Disorders. Springer, Berlin. https://doi.org/10.1007/978-3-319-97858-1
[93]	Scheen, A.J. (2018) Type 2 Diabetes and Thiazide Diuretics. Current Diabetes Reports, 18, Article No. 6. https://doi.org/10.1007/s11892-018-0976-6
[94]	Brunton, L., Chabner, B. and Knollman, B. (2018) Goodman & Gillman’s. The Pharmacological Basis of Therapy. 13th Edition, McGraw-Hill, New York.
[95]	Chaudhry, S. (2021) Scrupulously Managing Vertigo. Journal of Pharmaceutical and Biological Sciences, 9, 1-6. https://doi.org/10.18231/j.jpbs.2021.001
[96]	Molnár, A., Maihoub, S., Tamás, L. and Szirmai, á. (2019) Intratympanically Administered Steroid for Progressive Sensorineural Hearing Loss in Ménière’s Disease. Acta Oto-Laryngologica, 139, 982-986. https://doi.org/10.1080/00016489.2019.1658898
[97]	Wu, V., Sykes, E.A., Beyea, M.M., Simpson, M.T.W. and Beyea, J.A. (2019) Approach to Ménière Disease Management. Canadian Family Physician, 65, 463-467.
[98]	Smolka, W., Smolka, K., Markowski, J., Pilch, J., Piotrowska-Seweryn, A. and Zwierzchowska, A. (2020) The Efficacy of Vestibular Rehabilitation in Patients with Chronic Unilateral Vestibular Dysfunction. International Journal of Occupational Medicine and Environmental Health, 33, 273-282. https://doi.org/10.13075/ijomeh.1896.01330
[99]	Holmes, S., Lalwani, A.K. and Mankekar, G. (2021) Is Betahistine Effective in the Treatment of Ménière’s Disease? Laryngoscope, 131, 2639-2640. https://doi.org/10.1002/lary.29535
[100]	Liu, J.L., Liu, J.G., Chen, X.B. and Liu, Y.H. (2020) The Benefits of Betahistine or Vestibular Rehabilitation (Tetrax Biofeedback) on the Quality of Life and Fall Risk in Patients with Ménière’s Disease. The Journal of Laryngology & Otology, 134, 1073-1076. https://doi.org/10.1017/S0022215120002509
[101]	Dyhrfjeld-Johnsen, J. and Attali, P. (2019) Management of Peripheral Vertigo with Antihistamines: New Options on the Horizon. British Journal of Clinical Pharmacology, 85, 2255-2263. https://doi.org/10.1111/bcp.14046
[102]	Gruber, M., Cohen-Kerem, R., Kaminer, M. and Shupak, A. (2012) Vertigo in Children and Adolescents: Characteristics and Outcome. The Scientific World Journal, 2012, Article ID: 109624. https://doi.org/10.1100/2012/109624
[103]	Pellegrino, N., Di Stefano, V., Rotondo, E., Graziosi, A., Rispoli, M.G., Torrente, A., Lupica, A., Brighina, F., Raucci, U. and Parisi, P. (2022) Neurological Vertigo in the Emergency Room in Pediatric and Adult Age: Systematic Literature Review and Proposal for a Diagnostic Algorithm. Italian Journal of Pediatrics, 48, Article No. 125. https://doi.org/10.1186/s13052-022-01313-7
[104]	Zwergal, A. and Dieterich, M. (2020) Vertigo and Dizziness in the Emergency Room. Current Opinion in Neurology, 33, 117-125. https://doi.org/10.1097/WCO.0000000000000769
[105]	Edlow, J.A. and Newman-Toker, D. (2016) Using the Physical Examination to Diagnose Patients with Acute Dizziness and Vertigo. Journal of Emergency Medicine, 50, 617-628. https://doi.org/10.1016/j.jemermed.2015.10.040
[106]	Guth, P.S., Perin, P., Norris, C.H. and Valli, P. (1998) The Vestibular Hair Cells: Post-Transductional Signal Processing. Progress in Neurobiology, 54, 193-247. https://doi.org/10.1016/S0301-0082(97)00068-3
[107]	Soto, E., Vega, R. and Seseña, E. (2013) Neuropharmacological Basis of Vestibular System Disorder Treatment. Journal of Vestibular Research, 23, 119-37. https://doi.org/10.3233/VES-130494
[108]	Panula, P., Chazot, P.L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W.L., Stark, H., Thurmond, R.L. and Haas, H.L. (2015) International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacological Reviews, 67, 601-655. https://doi.org/10.1124/pr.114.010249
[109]	Sánchez-Borges, M. and Ansotegui, I.J. (2019) Second Generation Antihistamines: An Update. Current Opinion in Allergy and Clinical Immunology, 19, 358-364. https://doi.org/10.1097/ACI.0000000000000556
[110]	Massari, N.A., Nicoud, M.B. and Medina, V.A. (2020) Histamine Receptors and Cancer Pharmacology: An Update. British Journal of Pharmacology, 177, 516-538. https://doi.org/10.1111/bph.14535
[111]	Gutiérrez-Abejón, E., Herrera-Gómez, F. and álvarez, F.J. (2021) Trends in the Use of Antihistamines with Reference to Drivers between 2015 and 2019: A Population-Based Registry Analysis. Fundamental & Clinical Pharmacology, 35, 1168-1178. https://doi.org/10.1111/fcp.12680
[112]	Nyberg, S., Abbott, N.J., Shi, X., Steyger, P.S. and Dabdoub, A. (2019) Delivery of Therapeutics to the Inner Ear: The Challenge of the Blood-Labyrinth Barrier. Science Translational Medicine, 11, eaao0935. https://doi.org/10.1126/scitranslmed.aao0935
[113]	Amini, A., Heidari, K., Kariman, H., Taghizadeh, M., Hatamabadi, H., Shahrami, A., Derakhshanfar, H. and Asadollahi, S. (2015) Histamine Antagonists for Treatment of Peripheral Vertigo: A Meta-Analysis. The Journal of International Advanced Otology, 11, 138-142. https://doi.org/10.5152/iao.2015.1169
[114]	Fein, M.N., Fischer, D.A., O’Keefe, A.W. and Sussman, G.L. (2019) CSACI Position Statement: Newer Generation H1-Antihistamines Are Safer Than First-Generation H1-Antihistamines and Should Be the First-Line Antihistamines for the Treatment of Allergic Rhinitis and Urticaria. Allergy, Asthma & Clinical Immunology, 15, Article No. 61. https://doi.org/10.1186/s13223-019-0375-9
[115]	Chazot, P.L., Johnston, L., Mcauley, E. and Bonner, S. (2019) Histamine and Delirium: Current Opinion. Frontiers in Pharmacology, 10, Article 299. https://doi.org/10.3389/fphar.2019.00299
[116]	Chu, D.K., Oykhman, P. and Sussman, G.L. (2021) How to Use Antihistamines. Canadian Medical Association Journal, 193, E478-E479. https://doi.org/10.1503/cmaj.201959
[117]	Obara, I., Telezhkin, V., Alrashdi, I. and Chazot, P.L. (2020) Histamine, Histamine Receptors, and Neuropathic Pain Relief. British Journal of Pharmacology, 177, 580-599. https://doi.org/10.1111/bph.14696
[118]	Thurmond, R.L., Venable, J., Savall, B., La, D., Snook, S., Dunford, P.J. and Edwards, J.P. (2017) Clinical Development of Histamine H4 Receptor Antagonists. In: Hattori, Y. and Seifert, R., Eds., Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology, Vol. 241, Springer, Cham, 301-320. https://doi.org/10.1007/164_2016_130
[119]	Venail, F., Attali, P., Wersinger, E., Gomeni, R., Poli, S. and Schmerber, S. (2018) Safety, Tolerability, Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Modelling of the Novel H4 Receptor Inhibitor SENS-111 Using a Modified Caloric Test in Healthy Subjects. British Journal of Clinical Pharmacology, 84, 2836-2848. https://doi.org/10.1111/bcp.13744
[120]	Salcedo, C., Pontes, C. and Merlos, M. (2013) Is the H4 Receptor a New Drug Target for Allergies and Asthma? Frontiers in Bioscience, 5, 178-187. https://doi.org/10.2741/E606

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413